Skip to main content
Premium Trial:

Request an Annual Quote

AnPac Bio-Medical Nabs $7M Equity Investment for Cancer Early Detection Platform

NEW YORK – AnPac Bio-Medical Science said on Thursday that it has signed an agreement with Keystone Capital Partners for a preferred stock investment for an aggregate purchase price of $7 million.

The Shanghai-based firm will use the funding to advance its Cancer Differentiation Analysis (CDA) technology to provide cost-effective, early detection screening and testing of 26 cancers.

According to a prospectus summary filed with the US Securities and Exchange Commission, AnPac will offer 700,000 shares at a price of $10.00 per share to Keystone.

AnPac also noted that the investment will provide it with additional access to growth capital to expand its operations in China and continue commercialization efforts in the US.

The prospectus summary also noted that AnPac's proprietary CDA device uses an integrated sensor system to detect biophysical signals in blood samples. After collecting data on the signals, the firm uses its CDA technology and proprietary algorithm to measure and analyze the signals at multiple biological levels, including, protein, cellular, and molecular signals using multiple parameters.

The firm also said it offers biochemical, immunological, and genomic tests out of its CLIA-certified, CAP-accredited labs in the US and China.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.